Title: OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix
proteoglycan decorin in hepatocellular carcinoma
Version: 3 Date: 09 Sep 2024
Reviewer's report:
The authors demonstrated  that oncomiR-181a  downregulated  the expression of extracellular
matrix proteoglycan decorin in hepatocellular  carcinoma, along with a regulation on  tumor
suppressors and oncogenes. The authors have addressed the issues raised, improved the
methodology,  made accurate conclusions and  clarified the potential implications.
Title: OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix
proteoglycan decorin in hepatocellular carcinoma
Version: 3 Date: 09 Sep 2024
Reviewer's report:
The authors demonstrated  that oncomiR-181a  downregulated  the expression of extracellular
matrix proteoglycan decorin in hepatocellular  carcinoma, along with a regulation on  tumor
suppressors and oncogenes. The authors have addressed the issues raised, improved the
methodology,  made accurate conclusions and  clarified the potential implications.
Please review this paper.
user
Title: OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix
proteoglycan decorin in hepatocellular carcinoma
Version: 3 Date: 09 Sep 2024
Reviewer's report:
The authors demonstrated  that oncomiR-181a  downregulated  the expression of extracellular
matrix proteoglycan decorin in hepatocellular  carcinoma, along with a regulation on  tumor
suppressors and oncogenes. The authors have addressed the issues raised, improved the
methodology,  made accurate conclusions and  clarified the potential implications.
assistant